Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Jun 12:3:1204517.
doi: 10.3389/fradi.2023.1204517. eCollection 2023.

Editorial: Untangling post-treatment follow up of brain tumors: the role of neuroimaging

Affiliations
Editorial

Editorial: Untangling post-treatment follow up of brain tumors: the role of neuroimaging

Nicoletta Anzalone et al. Front Radiol. .
No abstract available

Keywords: MR; follow up of brain tumors; perfusion; radionecrosis; treatment effect.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors NA, LP and MC declared that they were an editorial board member of Frontiers at the time of submission. This had no impact on the peer review process and the final decision.

References

    1. Kumar AJ, Leeds NE, Fuller GN, Van Tassel P, Maor MH, Sawaya RE, et al. Malignant gliomas: MR imaging spectrum of radiation therapy and chemotherapy induced necrosis of the brain after treatment. Radiology. (2000) 217:377–84. 10.1148/radiology.217.2.r00nv36377 - DOI - PubMed
    1. Pruzincova L, Steno J, Srbecky M, Kalina P, Rychly B, Boljesikova E, et al. MR imaging of late radiation therapy and chemotherapy induced injury: a pictorial essay. Eur Radiol. (2009) 19:2716–27. 10.1007/s00330-009-1449-8 - DOI - PubMed
    1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphooorn MJB, et al. Radiotherapy plus concomitant and adjuvant temozolamide for glioblastoma. New Engl J Med. (2005) 352:987–96. 10.1056/NEJMoa043330 - DOI - PubMed
    1. Brandsma D, Stalpers L, Taal W, Sminia P, van den Bent MJ. Clinical features, mechanism, and management of pseudoprogression in malignant gliomas. Lancet Oncol. (2008) 9(5):453–61. 10.1016/S1470-2045(08)70125-6 - DOI - PubMed
    1. Thust SC, van den Bent MJ, Smits M. Pseudoprogression of brain tumors. J Magn Reson Imaging. (2018) 48(3):571–89. 10.1002/jmri.26171 - DOI - PMC - PubMed

Publication types

LinkOut - more resources